XORTX Therapeutics Inc (XRTX) — Capital Reinvestment Ratio

Latest as of December 2020: 0.00x

XORTX Therapeutics Inc (XRTX) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow (CA$1.57 Million) in capital expenditures (CA$2.84K). See debt-free asset ratio of XORTX Therapeutics Inc to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

CA$1.57 Million

CAD

Capital Expenditures

CA$2.84K

CAD

Data as of

Dec 2020

Most recent filing

XORTX Therapeutics Inc Capital Reinvestment Ratio (2017–2017)

This chart tracks XORTX Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Check XORTX Therapeutics Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for XORTX Therapeutics Inc (2017–2017)

Year-by-year Capital Reinvestment Ratio for XORTX Therapeutics Inc from 2017 to 2017. For live market cap and broader valuation context, see XORTX Therapeutics Inc market cap and net worth.

Year	Reinvestment Ratio	Operating CF (CAD)	Capital Expenditures	YoY Change
2017	0.01x	CA$91.17K	CA$1.17K	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow